$232.42
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Country

US

CEO

Mr. Jason Hollar

IPO date

1983

Employees

57,700

ISIN

US14149Y1082

Key stats

Open

$232.42

Volume

3.22M

Market cap

$55.54B

Prev. close

$233.77

Impl / hst vl

-

Open interest

$0.00

$232.42

Day’s Range

$232.42

$180.45

52W Range

$243.21

Valuation

22
Valuation score
Overvalued
P/E
36.00
P/S
0.22
P/B
-
Current ratio
0.91
Debt / Equity
-
ROE
-
Gross margin
4.10%
Income growth
-14.56%
FCF growth
202.16

Jul

15

Dividends

The last payment date was Jul 15, 2026

Div. per Share

$0.52

Div. Yield

0.22%

Payout Ratio

-

Div. Growth YoY

1.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 12 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$252.02
The top 18 analysts forecasts that 12-month price may increase by 8.43%, with a low of $219.40 and a high of $288.75
$219.40
Low
$252.02
Avg
$288.75
High
Current price

Earnings

Q1 ‘26 revenue
$60.94B
Q1 ‘26 net income
$399.00M
Revenue
Net income
Previous EPS
$2.63
Estimate EPS
$2.82
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply